Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 3 Interventional

Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD

ClinicalTrials.gov ID: NCT02727881

Public ClinicalTrials.gov record NCT02727881. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 7:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

OHR-1601: A Phase III Study of the Efficacy and Safety of Squalamine Lactate Ophthalmic Solution, 0.2% Twice Daily in Subjects With Neovascular Age-Related Macular Degeneration (AMD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 3 Study of the Efficacy and Safety of Squalamine Lactate Ophthalmic Solution 0.2% Twice Daily in Subjects with Neovascular Age-Related Macular Degeneration. Patients will receive injections of ranibizumab. In addition, patients will receive either Squalamine lactate 0.2% eye drops or Placebo eye drops. The study duration is approximately 9 months to primary endpoint

Study identification

NCT ID
NCT02727881
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ohr Pharmaceutical Inc.
Industry
Enrollment
230 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years to 110 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 12, 2016 (Actual)
Primary completion
Dec 2017 (Estimated)
Completion
Dec 2017 (Estimated)
Last update posted
Apr 27, 2017

2016 – 2017

United States locations

U.S. sites
118
U.S. states
34
U.S. cities
109
Facility City State ZIP Site status
Investigational Site Mobile Alabama 36608 —
Investigational Site Phoenix Arizona 85014 —
Investigational Site Phoenix Arizona 85020 —
Investigational Site Phoenix Arizona 85021 —
Investigational Site Tucson Arizona 85704 —
Investigational Site Arcadia California 91007 —
Investigational Site Beverly Hills California 90211 —
Investigational Site Campbell California 95008 —
Investigational Site Fullerton California 92835 —
Investigational Site Glendale California 91203 —
Investigational Site Glendora California 91741 —
Investigational Site La Jolla California 92093 —
Investigational Site Laguna Hills California 92653 —
Investigational Site Loma Linda California 92354 —
Investigational Site Los Angeles California 90017 —
Investigational Site Oceanside California 92056 —
Investigational Site Orange California 92868 —
Investigational Site Palm Desert California 92260 —
Investigational Site Palo Alto California 94303 —
Investigational Site Pasadena California 91107 —
Investigational Site Poway California 92064 —
Investigational Site Redlands California 92374 —
Investigational Site Sacramento California 91007 —
Investigational Site Bridgeport Connecticut 06606 —
Investigational Site Hamden Connecticut 06518 —
Investigational Site New London Connecticut 06320 —
Investigational Site Altamonte Springs Florida 32701 —
Investigational Site Boynton Beach Florida 33426 —
Investigational Site Fort Myers Florida 33901 —
Investigational Site Miami Florida 33136 —
Investigational Site Miami Florida 33143 —
Investigational Site Naples Florida 34103 —
Investigational Site Sarasota Florida 34233 —
Investigational Site Stuart Florida 34994 —
Investigational Site Augusta Georgia 30909 —
Investigational Site ‘Aiea Hawaii 96701 —
Investigational Site Berwyn Illinois 60402 —
Investigational Site Bloomington Illinois 61704 —
Investigational Site Chicago Illinois 60612 —
Investigational Site Sycamore Illinois 60178 —
Investigational Site New Albany Indiana 47150 —
Investigational Site Leawood Kansas 66211 —
Investigational Site Louisville Kentucky 40202 —
Investigational Site Paducah Kentucky 42001 —
Investigational Site Portland Maine 04102 —
Investigational Site Baltimore Maryland 21209 —
Investigational Site Baltimore Maryland 21237 —
Investigational Site Glen Burnie Maryland 21061 —
Investigational Site Hagerstown Maryland 21740 —
Investigational Site Pikesville Maryland 21208 —
Investigational Site Rockville Maryland 20877 —
Investigational Site Detroit Michigan 48201 —
Investigational Site Grand Rapids Michigan 49546 —
Investigational Site Jackson Michigan 49202 —
Investigational Site Royal Oak Michigan 48073 —
Investigational Site Southfield Michigan 48304 —
Investigational Site Traverse City Michigan 49686 —
Investigational Site Biloxi Mississippi 39532 —
Investigational Site Chesterfield Missouri 63017 —
Investigational Site Florissant Missouri 63031 —
Investigational Site Henderson Nevada 89052 —
Investigational Site Las Vegas Nevada 89144 —
Investigational Site Portsmouth New Hampshire 03801 —
Investigational Site Bloomfield New Jersey 07003 —
Investigational Site Lawrenceville New Jersey 08648 —
Investigational Site New Brunswick New Jersey 08901 —
Investigational Site Northfield New Jersey 08225 —
Investigational Site Ramsey New Jersey 07446 —
Investigational Site Teaneck New Jersey 07666 —
Investigational Site Toms River New Jersey 07083 —
Investigational Site Brooklyn New York 11223 —
Investigational Site Great Neck New York 11021 —
Investigational Site Hauppauge New York 11788 —
Investigational Site Lynbrook New York 11563 —
Investigational Site New York New York 10003 —
Investigational Site New York New York 10032 —
Investigational Site Rochester New York 14620 —
Investigational Site Rockville Centre New York 11570 —
Investigational Site Syracuse New York 13224 —
Investigational Site Charlotte North Carolina 28210 —
Investigational Site Concord North Carolina 28025 —
Investigational Site Cleveland Ohio 44122 —
Investigational Site Cleveland Ohio 44130 —
Investigational Site Cleveland Ohio 44195 —
Investigational Site Toledo Ohio 43615 —
Investigational Site Youngstown Ohio 44505 —
Investigational Site Ashland Oregon 97520 —
Investigational Site Camp Hill Pennsylvania 17011 —
Investigational Site Kingston Pennsylvania 18704 —
Investigational Site Lancaster Pennsylvania 17601 —
Investigational Site Philadelphia Pennsylvania 19104 —
Investigational Site Philadelphia Pennsylvania 19107 —
Investigational Site Philadelphia Pennsylvania 19116 —
Investigational Site Pittsburgh Pennsylvania 15213 —
Investigational Site Columbia South Carolina 29223 —
Investigational Site Greenville South Carolina 29605 —
Investigational Site Mt. Pleasant South Carolina 29464 —
Investigational Site Rapid City South Dakota 57701 —
Investigational Site Kingsport Tennessee 37660 —
Investigational Site Nashville Tennessee 37203 —
Investigational Site Fort Worth Texas 76107 —
Investigational Site Grapevine Texas 76051 —
Investigational Site Harlingen Texas 78550 —
Investigational Site Houston Texas 77030 —
Investigational Site Katy Texas 77494 —
Investigational Site Kingwood Texas 77339 —
Investigational Site McAllen Texas 78503 —
Investigational Site Plano Texas 75075 —
Investigational Site San Antonio Texas 78240 —
Investigational Site The Woodlands Texas 77384 —
Investigational Site Salt Lake City Utah 84107 —
Investigational Site Burlington Vermont 05401 —
Investigational Site Fairfax Virginia 22031 —
Investigational Site Warrenton Virginia 20186 —
Investigational Site Bellevue Washington 98004 —
Investigational Site Spokane Washington 99204 —
Investigational Site Morgantown West Virginia 26501 —
Investigational Site Madison Wisconsin 53705 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02727881, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 27, 2017 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02727881 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →